{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:20:10Z","timestamp":1792016410830,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:00:00Z","timestamp":1440028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jacc.2015.07.059","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T19:31:17Z","timestamp":1443468677000},"page":"1552-1562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":192,"title":["Usual Blood Pressure and Risk of New-Onset Diabetes"],"prefix":"10.1016","volume":"66","author":[{"given":"Connor A.","family":"Emdin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.07.059_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2015.07.059_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","article-title":"Diabetes and cardiovascular risk factors: the Framingham study","volume":"59","author":"Kannel","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.07.059_bib3","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/dc12-1513","article-title":"All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database","volume":"36","author":"Taylor","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2015.07.059_bib4","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ajh.2011.113","article-title":"Inflammation and hypertension: the interplay of\u00a0interleukin-6, dietary sodium, and the renin-angiotensin system in humans","volume":"24","author":"Chamarthi","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2015.07.059_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11906-000-0061-8","article-title":"Antihypertensive drugs and reversing of endothelial dysfunction in hypertension","volume":"2","author":"Taddei","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2015.07.059_bib7","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib8","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","article-title":"Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus","volume":"291","author":"Meigs","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.07.059_bib9","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/eurheartj\/ehm400","article-title":"Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study","volume":"28","author":"Conen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.07.059_bib10","doi-asserted-by":"crossref","first-page":"f2350","DOI":"10.1136\/bmj.f2350","article-title":"Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study","volume":"346","author":"Herrett","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2015.07.059_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2015.07.059_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1464-5491.2012.03698.x","article-title":"Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs","volume":"29","author":"Hex","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacc.2015.07.059_bib13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/sim.4780100703","article-title":"Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group","volume":"10","author":"Easton","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2015.07.059_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ije\/dyt077","article-title":"Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease","volume":"42","author":"Wormser","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacc.2015.07.059_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.07.059_bib16","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bmj.310.6979.560","article-title":"Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men","volume":"310","author":"Perry","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2015.07.059_bib22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.07.059_bib23","first-page":"487","article-title":"Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population","volume":"27","author":"Chihaoui","year":"2001","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jacc.2015.07.059_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/dc09-1654","article-title":"Long-term trends in cardiorespiratory fitness and the incidence of type 2 diabetes","volume":"33","author":"Sawada","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2015.07.059_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/1047-2797(94)00038-U","article-title":"Incidence and predictors of diabetes in Japanese-American men. The Honolulu Heart Program","volume":"5","author":"Burchfiel","year":"1995","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jacc.2015.07.059_bib26","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00004872-200209000-00035","article-title":"Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study","volume":"20","author":"Lindholm","year":"2002","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2015.07.059_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2006.04.030","article-title":"Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])","volume":"98","author":"Cooper-DeHoff","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.07.059_bib28","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","author":"McMurray","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2015.07.059_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/HYPERTENSIONAHA.108.114389","article-title":"Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute","volume":"52","author":"Carter","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2015.07.059_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive\u00a0protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.07.059_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jacc.2015.07.059_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.HYP.0000226046.58883.32","article-title":"Val-MARC Investigators. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial","volume":"48","author":"Ridker","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2015.07.059_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pds.2630030106","article-title":"The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions","volume":"3","author":"Van Staa","year":"1994","journal-title":"Pharmacoepidem Drug Safe"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715046951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715046951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T23:20:44Z","timestamp":1537312844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715046951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0735109715046951"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.07.059","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725826170.793510210","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usual Blood Pressure and Risk of New-Onset Diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}